The main thrust of research will be the prevention of renal disease and its
progression to the end-stage state (ESRD); such efforts will reduce or eve
n reverse the present epidemic of ESRD by the middle of the 21(st) Century.
In the meantime, the number of ESRD patients will continue to increase and
, unless xenotransplantation and cloning of one's own kidneys using stem ce
lls will provide an alternative, the various modes of dialysis will continu
e to be the principle treatment for an increasing numbers of ESRD patients.
Peritoneal dialysis (PD) has achieved success at certain salient points an
d, to advance further, the next generation of nephrologists will have to bu
ild on these. They include the following: PD is the treatment of choice for
children; it has low rates of peritonitis; it has similar (or in some coun
tries, better) survival rates than hemodialysis; it has lower costs; it has
adequate clearances through the introduction of automated PD; and it is an
effective treatment for those awaiting a kidney transplant. This report pr
esents the authors' views concerning the areas in which PD will improve in
the future. These include (1) a reduction in technique failure rates that w
ill allow us to maintain a larger number of patients on PD for 10 years or
more; (2) prevention of long-term changes of the peritoneal membrane throug
h the use of more "friendly" solutions; (3) prevention of malnutrition; (4)
the development of better peritoneal access devices; and (5) the increased
use of PD as the treatment of first choice for most ESRD patients. (C) 200
0 by the National Kidney Foundation, Inc.